Evaluation of a Brief Influencer-Delivered Body Image Video

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Start date pushed from Oct 5, 2026 to Oct 19, 2026
    • Study sites: 0 to 1
  2. Start date: Oct 5, 2026 to Oct 19, 2026
    • Secondary endpoints revised (5)
    • Study description expanded, about 2 words
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A 60-second video will be created by a high-engaging adult female influencer via a partnership with an influencer agency, Dove/Unilever, and CAR to be delivered by the same influencer to her followers on Instagram and TikTok. The video will focus on sharing an evidence-informed exercise to support challenging appearance ideals and the development of body confidence among adult women. The research will involve three distinct parts: * Conduct an online two-arm randomised control trial (RCT) with between 1000 to 1600 women to evaluate acceptability and efficacy of an influencer-delivered intervention video (versus an active control video) * Explore the feasibility of recruiting participants via influencers on their social media platforms in the same two-arm RCT * Conduct an online survey with 10-20 Canadian influencers recruited via an influencer agency to assess influencer opinions on creating and delivering evidence-based body image and other mental health content on their social media platforms, as well as their views on recruiting their followers for research participation
Trial Details
NCT Number NCT07850037
Lead Sponsor University of the West of England
Collaborators: Unilever R&D
Conditions
(from sponsor)		 Body Image
Enrollment 1,600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov